Skip to main content

CollPlant Biotechnologies Ltd

CLGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001631487

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding CollPlant Biotechnologies Ltd changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of CLGN: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders19117−1
Shares1.52M200.0K1.38M+63.6K (+4.8%)
Value$4.08M$538.0K$1.93M−$1.61M (−45.4%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CLGN in Q4 2025
InstitutionSharesValue% of portfolio
XTX Topco Ltd14,381$20.3K0.00%
Virtu Financial LLC11,806$17.0K0.00%
Legacy Wealth Managment, LLC3,472$4.86K0.00%

Sold out (4)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of CLGN in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Heights Capital Management, Inc19,258$51.8K
Royal Bank of Canada284$1.00K
National Bank of Canada250$670
Simplex Trading, LLC90$0

Not filed for Q4 2025 yet (1)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLGN in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
AMH Equity Ltd200,000$538.0K